ImmunologybioRxiv
Glucuronoxylomannan in the Cryptococcus species capsule as a target for CAR+ T-cell therapy
T. A. da Silva, P. J. Hauser, I. Bandey…·P. Kumaresan
This paper demonstrates that GXMR-CAR+ T cells can effectively target and reduce Cryptococcus neoformans burden in a murine model.
DOI 10.1016/j.jcyt.2020.11.002